Light Therapy for Chemotherapy-Induced Nerve Pain

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Recruiting N/A Interventional Study
Cancer Childhood Cancer Chemotherapy-induced Peripheral Neuropathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
20 (estimated)
Sponsor
Yale University · Other
Who this trial is looking for

This trial is looking for childhood cancer survivors who have nerve pain from chemotherapy. Participants will use a light therapy device at home for six weeks and share their experiences and symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I was diagnosed with cancer before the age of 21
  • I am at least five years old
  • I have received chemotherapy that can cause nerve pain
  • I have nerve pain that has been assessed by a trained physical therapist

You may not be able to join if

  • I am currently pregnant or breastfeeding
  • I cannot sit still for at least 15 minutes
  • I had nerve pain before my cancer treatment
  • I currently have cancer or a cancerous skin lesion
  • I have a tumor in my brain
  • I have an open wound or cancer lesion in the area being treated

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * History of childhood cancer (\<21 years of age at diagnosis) * Current age five years or older (due to availability of validated measures for CIPN in this age group) * History of exposure to vinca alkaloid, platinum, or other chemotherapeutic agent that can cause CIPN * CIPN a…
Contacts

Rozalyn Rodwin, MD

203-785-2407

rozalyn.rodwin@yale.edu

CONTACT

Jaime Rotatori, BSN, MS

203-785-2407

jaime.rotatori@yale.edu

CONTACT